Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1182
Gene Symbol: CLCN3
CLCN3 		0.300 Biomarker phenotype CTD_human A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. 21364753 2011
Entrez Id: 693120
Gene Symbol: MIR33B
MIR33B 		0.300 Biomarker phenotype CTD_human A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder. 30026881 2018
Entrez Id: 1081
Gene Symbol: CGA
CGA 		0.300 Biomarker phenotype CTD_human Hemiplegia after thyrotropin alfa in a hypothyroid patient with thyroid carcinoma metastatic to the brain. 10566621 1999
Entrez Id: 3552
Gene Symbol: IL1A
IL1A 		0.300 Biomarker phenotype CTD_human Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma. 27738319 2016
Entrez Id: 2247
Gene Symbol: FGF2
FGF2 		0.300 Biomarker phenotype CTD_human An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer. 12644816 2003
Entrez Id: 1969
Gene Symbol: EPHA2
EPHA2 		0.300 Biomarker phenotype CTD_human Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation. 21479221 2011
Entrez Id: 540
Gene Symbol: ATP7B
ATP7B 		0.300 Biomarker phenotype CTD_human Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin. 12509969 2003
Entrez Id: 6227
Gene Symbol: RPS21
RPS21 		0.300 Biomarker phenotype CTD_human A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. 21364753 2011
Entrez Id: 51728
Gene Symbol: POLR3K
POLR3K 		0.300 Biomarker phenotype CTD_human A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. 21364753 2011
Entrez Id: 8802
Gene Symbol: SUCLG1
SUCLG1 		0.300 Biomarker phenotype CTD_human A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. 21364753 2011
Entrez Id: 3191
Gene Symbol: HNRNPL
HNRNPL 		0.300 Biomarker phenotype CTD_human A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. 21364753 2011
Entrez Id: 1909
Gene Symbol: EDNRA
EDNRA 		0.300 Biomarker phenotype CTD_human Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis. 25194819 2014
Entrez Id: 407026
Gene Symbol: MIR29C
MIR29C 		0.300 Biomarker phenotype CTD_human A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder. 30026881 2018
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1 		0.300 Biomarker phenotype CTD_human miR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt/β-catenin signaling pathway. 27738331 2016
Entrez Id: 10061
Gene Symbol: ABCF2
ABCF2 		0.300 Biomarker phenotype CTD_human The role of ABC transporters in progression and clinical outcome of colorectal cancer. 22294766 2012
Entrez Id: 51035
Gene Symbol: UBXN1
UBXN1 		0.300 Biomarker phenotype CTD_human A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. 21364753 2011
Entrez Id: 5244
Gene Symbol: ABCB4
ABCB4 		0.300 Biomarker phenotype CTD_human The role of ABC transporters in progression and clinical outcome of colorectal cancer. 22294766 2012
Entrez Id: 6648
Gene Symbol: SOD2
SOD2 		0.300 Biomarker phenotype CTD_human Altered redox status accompanies progression to metastatic human bladder cancer. 18930813 2009
Entrez Id: 354
Gene Symbol: KLK3
KLK3 		0.300 Biomarker phenotype CTD_human An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer. 12644816 2003
Entrez Id: 27131
Gene Symbol: SNX5
SNX5 		0.300 Biomarker phenotype CTD_human A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. 21364753 2011
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Biomarker phenotype CTD_human HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes. 10897039 2000
Entrez Id: 79733
Gene Symbol: E2F8
E2F8 		0.300 Biomarker phenotype CTD_human Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma. 29754146 2018
Entrez Id: 6194
Gene Symbol: RPS6
RPS6 		0.300 Biomarker phenotype CTD_human A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. 21364753 2011
Entrez Id: 6137
Gene Symbol: RPL13
RPL13 		0.300 Biomarker phenotype CTD_human A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. 21364753 2011
Entrez Id: 57610
Gene Symbol: RANBP10
RANBP10 		0.300 Biomarker phenotype CTD_human A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. 21364753 2011